Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Sep;4(5):143-161.
doi: 10.1177/2049936117723228. Epub 2017 Aug 31.

Management of acute bacterial skin and skin structure infections with a focus on patients at high risk of treatment failure

Affiliations
Review

Management of acute bacterial skin and skin structure infections with a focus on patients at high risk of treatment failure

Abraham Pulido-Cejudo et al. Ther Adv Infect Dis. 2017 Sep.

Abstract

Over the last 25 years, the terminology of skin and soft tissue infections, as well as their classification for optimal management of patients, has changed. The so-called and recently introduced term 'acute bacterial skin and skin structure infections' (ABSSSIs), a cluster of fairly common types of infection, including abscesses, cellulitis, and wound infections, require an immediate effective antibacterial treatment as part of a timely and cautious management. The extreme level of resistance globally to many antibiotic drugs in the prevalent causative pathogens, the presence of risk factors of treatment failure, and the high epidemic of comorbidities (e.g. diabetes and obesity) make the appropriate selection of the antibiotic for physicians highly challenging. The selection of antibiotics is primarily empirical for ABSSSI patients which subsequently can be adjusted based on culture results, although rarely available in outpatient management. There is substantial evidence suggesting that inappropriate antibiotic treatment is given to approximately 20-25% of patients, potentially prolonging their hospital stay and increasing the risk of morbidity and mortality. The current review paper discusses the concerns related to the management of ABSSSI and the patient types who are most vulnerable to poor outcomes. It also highlights the key management time-points that treating physicians and surgeons must be aware of in order to achieve clinical success and to discharge patients from the hospital as early as possible.

Keywords: acute bacterial skin and skin structure infection; appropriate antibiotic therapy; methicillin-resistant Staphylococcus aureus; poor outcome; severity; treatment failure.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: Dr A Ortiz-Covarrubias has received honorarium fees as speaker from Bayer HealthCare, Sanofi, Abbott, MSD, and Silanes Labs. He has also received research funds from MSD, Astellas Pharma, and Glaxo Smith Kline. Dr A Jalife-Montaño has received honorarium fees as speaker from Farmasa. Professor A Pulido-Cejudo has received honorarium fees as speaker from Bayer HealthCare, Bard Davol, and Covidien. Dr M Guzmán-Gutierrez, Dr JL Martínez-Ordaz, Dr HF Noyola-Villalobos, and Dr LM Hurtado-López have no conflict of interest.

Figures

Figure 1.
Figure 1.
Distribution of skin infection types in different regions.,– DFI, diabetic foot infection; N/A, not available; uSSSI, uncomplicated skin and skin structure infection. aPatients could have had ⩾1 diagnosis; wound infections refer to post-surgical and post-traumatic infections.
Figure 2.
Figure 2.
Representative images of ABSSSI indications: (a) Infected wound, (b) Abscess and (c) Cellulitis. Images belong to the corresponding author. ABSSSI, acute bacterial skin and skin structure infection.

References

    1. Edelsberg J, Taneja C, Zervos M, et al. Trends in US hospital admissions for skin and soft tissue infections. Emerg Infect Dis 2009; 15: 1516–1518. - PMC - PubMed
    1. Garau J, Ostermann H, Medina J, et al. Current management of patients hospitalized with complicated skin and soft tissue infections across Europe (2010–2011): assessment of clinical practice patterns and real-life effectiveness of antibiotics from the REACH study. Clin Microbiol Infect 2013; 19: E377–E385. - PubMed
    1. Bassetti M, Baguneid M, Bouza E, et al. European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid. Clin Microbiol Infect 2014; 20(Suppl. 4): 3–18. - PubMed
    1. May AK. Skin and soft tissue infections. Surg Clin North Am 2009; 89: 403–420. - PubMed
    1. May AK. Skin and soft tissue infections: the new surgical infection society guidelines. Surg Infect 2011; 12: 179–184. - PubMed

LinkOut - more resources